Tenapanor in Synucleinopathy-Related Constipation

Study overview

Investigation of tenapanor as a potential treatment for synucleinopathy-associated constipation

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Collaborators and Investigators

Cedar Valley Digestive Health Center,

Richard A. Manfready, MD, AM, FACP, PRINCIPAL_INVESTIGATOR, Cedar Valley Digestive Health Center

Ravindra Mallavarapu, MD, STUDY_CHAIR, Cedar Valley Digestive Health Center

Harichandana Punukula, PharmD, MS, STUDY_DIRECTOR, Cedar Valley Digestive Health Center

Study Record Dates

2027-03